pharmaphorum

MAY 3, 2017

Growing patient influence combined with new technologies and the requirements of new reimbursement models means clinical research is undergoing rapid transformation. Industry is being compelled to move towards more patient centric solutions to keep up with these changes. With healthcare stakeholders in agreement that patient engagement is key to realising the value of clinical trials, regulators, sponsors, CROs, research funders and publishers are all moving towards more patient-focused models.

Medical Records 52

Medical Records 52

Med Ed 101

MAY 3, 2017

So the FDA changed the labeling on metformin a while back and made it a little easier to use the drug in more patients who have poor kidney function. Whenever changes like this happen, I like to take a little time and digest the changes. From a recent Medscape article, here’s what one physician, Dr Inzucch, […]. The post FDA Metformin Kidney Function Dosing Changes – What are you Going to do?

FDA 40

FDA Labelling 40

Med Ed 101

APRIL 30, 2017

Hypertension management can get a little overwhelming sometimes since there are so many medications to choose from. We often use multiple medications with different mechanisms of action to treat hypertension. If a patient is already on a medication at a moderate or low dose, what should we do if blood pressure remains elevated? I’m going […].

40

40